Showing results (191-200 of 241) with videos related to

Sort By:
Pageof 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2008
Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17Hyman B Muss, Dongsheng Tu, James N Ingle, et al.
Breast Cancer Research and Treatment|April 27, 2016
Relapse-free survival of statistically standardized continuous RT-PCR estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2): NCIC CTG MA.14Judith-Anne W Chapman, Dennis C Sgroi, Paul E Goss, et al.
Breast Cancer Research and Treatment|August 21, 2021
Phase II trial of veliparib and temozolomide in metastatic breast cancer patients with and without BRCA1/2 mutationsJing Xu, Tanya E Keenan, Beth Overmoyer, et al.
World Journal of Clinical Oncology|December 11, 2014
Competing risks of death in younger and older postmenopausal breast cancer patientsJudy-Anne W Chapman, Kathleen I Pritchard, Paul E Goss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2006
Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17Edith A Perez, Robert G Josse, Kathleen I Pritchard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
Phase II study of dexverapamil plus anthracycline in patients with metastatic breast cancer who have progressed on the same anthracycline regimenE Warner, D Hedley, I Andrulis, et al.
Breast Cancer Research and Treatment|June 8, 2010
Aromatase immunoreactivity is increased in mammographically dense regions of the breastCeline M Vachon, Hironobu Sasano, Karthik Ghosh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 3, 2012
Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozoleP E Goss, J N Ingle, S Martino, et al.
Journal of Palliative Care|March 26, 2019
Symptom Assessment and Early Access to Supportive and Palliative Care for Patients With Advanced Solid Tumors in MexicoMirza Jacqueline Alcalde-Castro, Enrique Soto-Perez-de-Celis, Alfredo Covarrubias-Gómez, et al.
The Lancet. Oncology|February 10, 2012
Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trialAngela M Cheung, Lianne Tile, Savannah Cardew, et al.
Pageof 25